Neurotech Announces Positive Phase 2 Results in NT-501 (CNTF) for Macular Telangiectasia.

About Us Science & Technology Clinical Patients News Careers Publications Contact Us Supplier Code of Conduct Policy Accessibility Statement Privacy Policy Terms and Conditions of Use Policy